Loading...
TrendSpott

TrendSpott

TrendSpott
 
 
Viking Therapeutics
16.65
-3.92%
 
Recommendation
VKTX Viking Therapeutics
  Login
 
 
Last Price
 
Change
 
16.65
 
-3.92%
 
 

 
Sentiment
 
  Login to display
 
 

11.03

8.44

4.06

2.73

 
 
1m
3m
6m
1y
 

Summary

  Login to display Viking Therapeutics (VKTX) recommendation from the last 90 days from financial news and social media.
 

Rewards

Rewards

 Earnings are forecast to grow

 
 

Risk Level

 
TrendSpott
 

Viking Therapeutics (VKTX) has Low Risk Level

Click here to check what is your level of risk

 

Analysts Opinion

Click on the category for more information
 
 
Earnings ×
 

Earnings

4.00
 

TrendSpott

 Above analyst estimates

 
 
Rating ×
 

Rating

NA
 
 
Momentum ×
 

Momentum

4.00
 

TrendSpott

 Has been gaining momentum

 
Activity ×
 

Activity

3.68
 

TrendSpott

 Debt capital raise

 
Future ×
 

Future

3.75
 

TrendSpott

 Earnings are forecast to grow

 
 

Analysts Opinion

Analysts opinion is negative and it remained unchanged from the past 3 months

 

Street Consensus

Buy
Opinion
Trend
Score
Potential
Score
 
83%
NA
100%
75%
 
On Track
On Track
On Track
 

Street Opinion 

Street view is extremely ish and have positive views on the near-term outlook

 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
 
83%
10%
Positive
Negative
25 out of 30
events present
3 out of 30
events present
 

 
Events Calendar
Click for more information
 
February
S
M
T
W
T
F
S
March
S
M
T
W
T
F
S
 
Highlights
Last
Modify
Closing
Price
%
Change
 
Options Activity
1 Day Ago
16.65
-3.92%
 
Capital Raise
This Week
17.33
+8.79%
 
Strong Earnings
This Week
15.44
+69.30%
 
Investors Activity
2 Month Ago
9.96
+4.18%
 
Top Headlines

unusual call option trade in viking therapeutics (vktx) worth $659.70k. on march 31 2023 at 14:16:36 et an unusually large $659.70k block of call contracts in viking therapeutics (vktx) was bought with a

Fri Mar 31, 2023

Momentum

why shares of viking therapeutics skyrocketed this week. what happened shares of viking therapeutics (nasdaq: vktx) were up 89.7% for the week as of thursday afternoon after being up as much as 95.5% for the week according to data provided by s

Thu Mar 30, 2023

Momentum

viking therapeutics sheds on pricing $250m stock offering.

Thu Mar 30, 2023

Activity

viking therapeutics prices 17.24 mln share offering. (rttnews) - viking therapeutics inc. (vktx) thursday priced its public offering of 17.24 million shares at $14.50 per share.

Thu Mar 30, 2023

Activity

viking therapeutics announces proposed public offering of common stock.

Wed Mar 29, 2023

Activity

viking therapeutics proposes stock offering size not disclosed.

Wed Mar 29, 2023

Activity

up 463% this sizzling growth stock could have a lot more room to run. viking therapeutics (nasdaq: vktx) a small-cap biotech has been on quite the ride over the past few months. thanks to a positive late-stage trial in nonalcoholic steatohepatit

Wed Mar 29, 2023

Activity
Activity
Potential

viking therapeutics initial vk2735 data resoundingly beat expectations analyst says. earlier today) announced the first-in-human single-ascending dose and multiple-ascending dose data of vk2735. all cohorts showed up to 7.8% reductions in body weight f

Tue Mar 28, 2023

Earnings

heres why viking therapeutics rose over 50% on obesity drug data. clinical-stage biotechnology company viking therapeutics inc. (nasdaq: vktx) stock jumped more than 50% on positive phase 1 data on its novel dual glp-1/glp agonist compound vk2

Tue Mar 28, 2023

Activity
Momentum

why viking therapeutics stock is soaring tuesday. ) shares are trading higher tuesday after the companyreported results from its phase 1 trial of vk2735for the potential treatment of various metabolic disorders.

Tue Mar 28, 2023

Momentum

viking therapeutics: phase 1 vk2735 clinical trial reports positive results. (rttnews) - viking therapeutics inc. (vktx) a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders announced tuesday positive results f

Tue Mar 28, 2023

Activity

viking therapeutics announces results from phase 1 clinical trial of dual glp-1/gip receptor agonist vk2735. up to 6.0% placebo-adjusted mean weight loss (7.8% from baseline) observed after 28 days vk2735 shown to be safe and well-tolerated in 28-day stu

Tue Mar 28, 2023

Activity

viking therapeutics: some caution warranted.

Thu Mar 16, 2023

Potential

viking therapeutics to present at svb securities global biopharma conference.

Tue Feb 7, 2023

Activity

analyzing viking therapeuticss short interest. ) short percent of float has risen 7.17% since its last report. the company recently reported that it has

Tue Jan 3, 2023

Activity

viking therapeutics sues ascletis pharma for stealing trade secrets.

Tue Jan 3, 2023

Activity

 
 
 
TrendSpott

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

TrendSpott on Twitter TrendSpott on YouTube TrendSpott on stocktwits TrendSpott Rss
 

Receive our daily VKTX alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

 
Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

 
Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
About Us

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by TrendSpott including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
TrendSpott

TrendSpott

Get the pulse of the market

 
TrendSpott

TrendSpott

VKTX Viking Therapeutics

Last Price
16.65
Change
-3.92%
Recommendation
  Login to display
 

Summary

  Login to display Viking Therapeutics (VKTX) recommendation from the last 90 days from financial news and social media.

 
 
11.03
8.44
4.06
2.73
 
 
1m
3m
6m
1y
 
Sentiment
 

  Login to display

Rewards

Rewards

 Earnings are forecast to grow

 
 
 
 
Street Consensus
 
Buy
Opinion
Trend
Score
Potential
Score
 
NA
100%
75%
On Track
On Track
On Track
 
83%
10%
Positive
Negative
25 out of 30
events present
3 out of 30
events present
 

Street Opinion

Street view is extremely ish and have positive views on the near-term outlook

 
 
Analysts Opinion
Hover the category for more information
 
 
Earnings ×
 

Earnings

4.00
 

TrendSpott

 Above analyst estimates

 
 
Rating ×
 

Rating

NA
 
 
Momentum ×
 

Momentum

4.00
 

TrendSpott

 Has been gaining momentum

 
Activity ×
 

Activity

3.68
 

TrendSpott

 Debt capital raise

 
Future ×
 

Future

3.75
 

TrendSpott

 Earnings are forecast to grow

 
 

Analysts Opinion

Analysts opinion is negative and it remained unchanged from the past 3 months

 
 
 
 
 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 
Risk Level
 
TrendSpott
 

Viking Therapeutics (VKTX) has Low Risk Level.  Click here to check what is your level of risk

 
 
 

Events Calendar

Hover for information

 
February
 
S
M
T
W
T
F
S
 
March
 
S
M
T
W
T
F
S
 
 
 
 
Highlights
Last
Modify
Closing
Price
%
Change
 
Options Activity
1 Day Ago
16.65
-3.92%
 
Capital Raise
This Week
17.33
+8.79%
 
Strong Earnings
This Week
15.44
+69.30%
 
Investors Activity
2 Month Ago
9.96
+4.18%
 
 
 
TrendSpott

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

TrendSpott on Twitter TrendSpott on YouTube TrendSpott on stocktwits TrendSpott Rss

 

Receive our daily VKTX Alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by TrendSpott including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
 
 

Top Headlines